Preoperative stage T1 (120 patients) |
Follow-up: 253 mo |
Patients with stage T1 before radiotherapy |
Probability of death (95%CI) |
0.47 (0.21-0.64) |
Events (n) |
22 |
Stage T2 before radiotherapy (185 patients) |
Follow-up: 255 mo |
Patients with stage T2 lesions before radiotherapy |
Probability of local recurrence or |
0.13 (0.08-0.18) |
metastasis (95%CI) |
Events (n) |
21 |
Probability of cancer-specific death (95%CI) |
0.07 (0.03-0.12) |
Events (n) |
10 |
Probability of death (95%CI) |
0.50 (0.21-0.68) |
Events (n) |
33 |
Stage T3 before radiotherapy (120 patients) |
Follow-up: 239 mo |
Patients with stage T3 lesions before radiotherapy |
Probability of local recurrence or |
0.12 (0.05-0.17) |
metastasis (95%CI) |
Events (n) |
13 |
Probability of cancer-specific death (95%CI) |
0.11 (0.06-0.17) |
Events (n) |
11 |
Probability of death (95%CI) |
0.55 (0.33-0.70) |
Events (n) |
33 |